An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Our objective was to investigate local immune status and its prognostic value in lung adenocarcinoma. A cohort of 513 lung adenocarcinoma samples from TCGA and ImmPort databases was collected and analyzed. The R package coxph was employed to mine immune-related genes that were significant prognostic indictors by both univariate and multivariate analyses. The R software package glmnet was then used for lasso cox regression analysis, and a prognosis prediction model was constructed for lung adenocarcinoma; clusterProfiler was selected for functional gene annotations and KEGG analysis. Finally, correlations between the RiskScore and clinical features or signaling pathways were established.Sixty-four immune-related genes were remarkably correlated with patient prognosis and were further applied. Samples were hierarchically clustered into two subgroups and those in each subgroup were different in terms of the distribution of race, age, tumor stage, receptor status, histological type, metastasis status, and patient prognosis. Based on this, the lasso regression algorithm was employed to screen the 14 most representative immune-related genes (PSMD11, PPIA, MIF, BMP5, DKK1, PDGFB, ANGPTL4, IL1R2, THRB, LTBR, TNFRSF1, TNFRSF17, IL20RB, and MC1R) with respect to patient prognosis. Then, the prognosis prediction model for lung adenocarcinoma patients (namely, the RiskScore equation) was constructed and the training set samples were incorporated to evaluate the efficiency of this model to predict and classify patient prognosis. Subsequently, based on functional annotations and KEGG pathway analysis, the 14 immune-related genes were mainly enriched in pathways closely associated with lung adenocarcinoma and its immune microenvironment, such as cytokine–cytokine receptor interaction and human T-cell leukemia virus 1 infection. Furthermore, correlations between the RiskScore and the clinical features of training set samples and signaling pathways (such as P53, cell cycle and DNA repair) were also demonstrated. Finally, the test set sample data were employed for independent testing and verification of the model.We established the prognostic prediction RiskScore model based on the expression profiles of 14 immune-related genes, which shows high prediction accuracy and stability in identifying immune features. This could provide clinical guidance for the diagnosis and prognosis of different immunophenotypes, and suggests multiple targets for precision lung adenocarcinoma therapy based on subtype-specific immune molecules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440 · cited 2×
“Then, the ssGSEA function of the R software package GSVA (19) was utilized to analyze the KEGG functional enrichment score of each sample in the training set.”
MethodComprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
Gene-expression profiles predict survival of patients with lung adenocarcinoma
Beer, D. G., Kardia, S. L. R., Huang, C.-C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., et al. (2002) · Nature Medicine · doi:10.1038/nm733 · Cited by 2,025 · cited 1×
“First, the tumor tissues were pre-processed, by the following steps: (1) removing samples with no clinical data, (2) removing the normal tissue sample data, (3) removing the genes of FPKM < 1 from all samples, (4) preserving only the expression profiles of immune-related genes, and (5) filtering out genes with exceedi…”
MethodLi, B., Cui, Y., Diehn, M., & Li, R. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.1609 · Cited by 514 · cited 1×
“the application of systemic adjuvant chemotherapy after surgery remains a source of controversy in clinics (21).”
Background
Cited by
Identification and Experimental Validation of Marker Genes between Diabetes and Alzheimer’s Disease
Huang, C., Wen, X., Xie, H., Hu, D., & Li, K. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8122532 · Cited by 15
“Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses [25] were executed by using clusterPro fi ler package [26] (version 3.16.0) in R software (version 4.0.2) for function annotating and pathway predicting.”
Influential
Metadata
- Authors
- Zhang, M., Zhu, K., Pu, H., Wang, Z., Zhao, H., Zhang, J., & Wang, Y.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2019-12-10
- Volume
- 9
- Pages
- 1314-1314
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2996012059
- Cited by
- 177
- References
- 5
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma. https://app.cochat.ai/papers/10.3389/fonc.2019.01314
- The paper
- Zhang, M., Zhu, K., Pu, H., Wang, Z., Zhao, H., Zhang, J., & Wang, Y. (2019). An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma. Frontiers in Oncology. https://doi.org/10.3389/fonc.2019.01314
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.